At this rate I'd expect some buying for the dividend next week - xd 14 Nov (15p/share) |
I think his main remit and focus reading is on chemicals in food and not drugs for medical conditions |
Still blue on the day though. Healthcare -1.25% |
FTSE has dropped 70pts from this morning. |
This drop is specifically pharma / healthcare related. Trump will give a major role to Bobby Kennedy and he's a well known critic of vaccine safety |
Most of UK falling now, so normal service resumed on the UK mkt after an exciting 3 hour break |
GSK & AZN both falling now. |
China already bashed GSK some years ago so hopefully not in their crosshairs again! |
AZN? No linkage there! |
"Early data release on weight loss drug portfolio disappoints"
AstraZeneca fell 8.2%, losing its top spot as the most valuable company on the FTSE 100 to oil major Shell in the process.
The Cambridge-based pharmaceuticals firm fell back following the release of early data on its weight loss drug portfolio.AstraZeneca had revealed early data for its prospective weight loss drug at the ObesityWeek 2024 meeting in San Antonio, Texas on Monday.
Deutsche Bank reiterated a 'sell' rating following the update, noting the GLP-1 data "was somewhat underwhelming".
Jefferies took a less pessimistic view noting the data was "largely incremental, as expected."
After the closing bell, AstraZeneca noted its share price movement. It said it is not commenting on "speculative media reports including those related to ongoing investigations in China".
"If requested, we will fully cooperate with the Chinese authorities," Astra said. |
It's fairly old News that though |
It may be that AZN is down on this:
Report finds China targeted AstraZeneca in fraud probe over cancer treatment
The pharmaceutical giant, whose China chief is now under investigation, was previously at the centre of insurance scam cases, report says |
Think it might be down on back of yet another court action but this time against Astra-Zeneca and the covid jab
I will suffer the consequences as will we all |
It is today at these prices. Money being pulled from UK funds as per usual |
Not sure why GSK is down ANOTHER 1.5% today - this used to be a quality company to own ?! |
PEAT
Just got given a few more at 1402
Now I am happy
Hope this satisfies your mendacious misguided comments
Regards
Jibby |
I would prefer it to be a £90 billion company.. :) |
Love to see the attempts at deramping (and ramping for that matter) a 60 billion company! But come on advfnets, buy 500 quids worth please. |
For goodness sake Mr De-ramper, please calm down. I am sure none of us are going to panic sell due to your terrifying assessment. Halloween was yesterday. |
I added again yesterday at 13.73 which now seems well timed. Better than my larger purchase at 14.73 last month…large overseas earners would benefit from a weaker pound and a hedge against uk inflation |
Had some chunky dividends to re-invest somewhere, so decided to follow in Lady Susan Symonds footsteps and add to my GSK holding this morning - but not expecting any quick recovery here, FTSE/UK is very unloved at the moment! |
You're obviously deramping with your recent posts! ;0] |
Wait as 2025 news shock the market as more falls to come....
Too Risky at these levels.. |
Profits and sales rising so she ain't doing anything wrong |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
